Aggregated
67% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Citizens Capital Markets
A Citizens Capital Markets analyst with 22 tracked ratings across 19 distinct tickers has a 66.7% success rate on the captured sample, focusing on both covered sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| ALT | 2025-04-02 | buy | $25.00 | Aggregated |
| ALTALTIMMUNE INC | 2025-04-02 | unknown | $25.00 | Aggregated |
| AURAAURA BIOSCIENCES INC | 2025-03-26 | unknown | $19.00 | Aggregated |
| KALV | 2025-03-26 | buy | $19.00 | Aggregated |
| KALVKALVISTA PHARMACEUTICALS INC | 2025-03-26 | unknown | $19.00 | Aggregated |
| SKYE | 2025-03-21 | buy | $15.00 | Aggregated |
| ALT | 2025-03-14 | buy | $25.00 | Aggregated |
| PTGXPROTAGONIST THERAPEUTICS INC | 2025-03-10 | unknown | $61.00 | Aggregated |
| DBVT | 2025-03-04 | buy | $10.00 | Aggregated |
| DBVTDBV TECHNOLOGIES - ADR | 2025-03-04 | unknown | $10.00 | Aggregated |
| OCUL | 2025-03-04 | buy | $19.00 | Aggregated |
| OCULOCULAR THERAPEUTIX INC | 2025-03-04 | unknown | $19.00 | Aggregated |
| ATXSASTRIA THERAPEUTICS INC | 2025-03-03 | unknown | $26.00 | Aggregated |
| BCRX | 2025-03-03 | buy | $18.00 | Aggregated |
| BCRXBIOCRYST PHARMACEUTICALS INC. | 2025-03-03 | unknown | $18.00 | Aggregated |
| KALV | 2025-03-03 | buy | $19.00 | Aggregated |
| PHVS | 2025-03-03 | buy | $55.00 | Aggregated |
| PHVSPHARVARIS NV | 2025-03-03 | unknown | $55.00 | Aggregated |
| CRNXCRINETICS PHARMACEUTICALS INC | 2025-02-28 | unknown | $91.00 | Aggregated |
| GPCR | 2025-02-28 | buy | $87.00 | Aggregated |
| GPCRSTRUCTURE THERAPEUTICS INC - ADR | 2025-02-28 | unknown | $87.00 | Aggregated |
| BCRX | 2025-02-25 | buy | $18.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| ALT | 2 | 2025-04-02 | Aggregated |
| ALTALTIMMUNE INC | 1 | 2025-04-02 | Aggregated |
| AURAAURA BIOSCIENCES INC | 1 | 2025-03-26 | Aggregated |
| KALV | 2 | 2025-03-26 | Aggregated |
| KALVKALVISTA PHARMACEUTICALS INC | 1 | 2025-03-26 | Aggregated |
| SKYE | 1 | 2025-03-21 | Aggregated |
| PTGXPROTAGONIST THERAPEUTICS INC | 1 | 2025-03-10 | Aggregated |
| DBVT | 1 | 2025-03-04 | Aggregated |
| DBVTDBV TECHNOLOGIES - ADR | 1 | 2025-03-04 | Aggregated |
| OCUL | 1 | 2025-03-04 | Aggregated |
| OCULOCULAR THERAPEUTIX INC | 1 | 2025-03-04 | Aggregated |
| ATXSASTRIA THERAPEUTICS INC | 1 | 2025-03-03 | Aggregated |
| BCRX | 2 | 2025-03-03 | Aggregated |
| BCRXBIOCRYST PHARMACEUTICALS INC. | 1 | 2025-03-03 | Aggregated |
| PHVS | 1 | 2025-03-03 | Aggregated |
| PHVSPHARVARIS NV | 1 | 2025-03-03 | Aggregated |
| CRNXCRINETICS PHARMACEUTICALS INC | 1 | 2025-02-28 | Aggregated |
| GPCR | 1 | 2025-02-28 | Aggregated |
| GPCRSTRUCTURE THERAPEUTICS INC - ADR | 1 | 2025-02-28 | Aggregated |